Wordt geladen...
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
BACKGROUND: Macrophage activation syndrome (MAS) is a potentially fatal complication of systemic inflammation. HMGB1 is a nuclear protein released extracellularly during proinflammatory lytic cell death or secreted by activated macrophages, NK cells, and additional cell types during infection or ste...
Bewaard in:
| Gepubliceerd in: | Mol Med |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8111379/ https://ncbi.nlm.nih.gov/pubmed/33975537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10020-021-00308-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|